Shire Says FDA Approves ADHD Patch For Teens Ages 13-17 FOXBusiness ... and US Attorney for the Eastern District of Pennsylvania asked for documents related to the sales and marketing of Adderall XR, Daytrana and Vyvanse. ... and more » |
Shire Says FDA Approves ADHD Patch For Teens Ages 13-17 Capital.gr (press release) ... and US Attorney for the Eastern District of Pennsylvania asked for documents related to the sales and marketing of Adderall XR, Daytrana and Vyvanse. ... and more » |
Shire US Marketing Probe Early Stage, Routine In Indus-CEO Wall Street Journal ... for the Eastern District of Pennsylvania, seeking production of documents related to the sales and marketing of Adderall XR, Daytrana and Vyvanse. ... UPDATE 1-Shire Q3 beats forecasts, boosted by new drugs Reuters Shire Swings To 3Q Profit; Vela For Up To 600 Patients NASDAQ Shire swings to quarterly profit, revenue dips MarketWatch Interactive Investor - ShareCast all 20 news articles » |
Shire Subpoenaed In US Drug Marketing Probe Wall Street Journal ... Attorney for the Eastern District of Pennsylvania, seeking production of documents related to the sales and marketing of Adderall XR, Daytrana and Vyvanse. |